A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

The expansion of the advanced therapy medicinal products market is primarily fueled by the increasing incidence of chronic diseases. The rising prevalence of genetic disorders and cancer, along ...

CRISPR technology, driven by Cas9, redefines gene editing, facilitating targeted DNA modifications that advance genetic ...

Citi analyst Yigal Nochomovitz lowered the firm’s price target on Crispr Therapeutics (CRSP) to $82 from $89 and keeps a Buy rating on the ...

Researchers find a master epigenetic switch that activates silenced genes to compensate for their missing counterparts in a ...

周三（2月12日），投资者纷纷买入CRISPR Therapeutics（CRSP）股票，该股在交易时段结束时上涨超过9%。这家专业医疗公司周二盘后发布的最新季度财报让投资者大受鼓舞。这一超过9%的涨幅与标普500指数0.3%的跌幅形成鲜明对比。

If you’re on the fence about investing in CRISPR Therapeutics AG or Exact Sciences Corporation because you’re not sure how they measure up, it’s important to compare them on a few factors before ...

Discover the Top 20 best Fashion Logos that define style in the industry! From iconic to innovative, explore how these logos captivate audiences! In fashion, logos are more than just symbols; they are ...

Crispr Therapeutics reported end-2024 results in line with our expectations and Crispr’s diverse pipeline is continuing to make progress. We maintain our fair value estimate of $106 per share ...